initial public offerings (IPOs) trading on American exchanges
Showing posts with label SWAV. Show all posts
Showing posts with label SWAV. Show all posts

Monday, September 2, 2019

IPOs this week : Sept 2 - 6, 19 (wk 36)

More crickets in the IPO market next week.

The quiet period expiration expires on Immode (NASDAQ:INMD) on September 3, while IPO share lockups arrive on Shockwave Medical (NASDAQ:SWAV) on September 3 and Futu Holdings (NASDAQ:FHL) on September 4.

The Asia IPO scene is just as inactive as the U.S. amid trade war concerns and Hong Kong protests, but one company wading into the IPO waters bravely is Alibaba (NYSE:BABA)-backed Megvii Technology. The AI services startup saw revenue triple to 949M yuan ($132M) during the first half of the year. Lenovo Group (OTCPK:LNVGY) and China Mobile (NYSE:CHL) are also backers of Megvii.

Monday, April 1, 2019

IPOs this week : April 1 - 5, 19 (wk 14)

Expected IPO pricings:
  • Ruhnn Holding (RUHN) on April 2; 
  • Silk Road Medical (SILK), NGM Biopharmaceuticals (NGM) and Tradeweb Markets (TW) on April 3.

IPO lockup expirations:
  • Upwork (NASDAQ:UPWK) and Guardant Health (NASDAQ:GH) on April 1; 
  • Kodiak Sciences (NASDAQ:KOD) on April 2; 
  • Elastic (NYSE:ESTC) on April 3.

IPO quiet period expirations:
  • Shockwave Medical (NASDAQ:SWAV) on April 1 and 
  • Futu (NASDAQ:FHL) on April 2.

Monday, March 4, 2019

IPOs this week : March 4 - 8, 2019

Things are starting to get a little more interesting in the IPO market after a snail's pace for most of 2019. Lyft (LYFT) filed for its IPO, while Peloton (PTON) and Chinese coffee chain Luckin are both moving in that direction. Lyft is reportedly hoping to draw a valuation of between $20B and $25B.

IPOs expected to price
This week, IPO pricings are anticipated for

  • Shockwave Medical (SWAV) on March 6 and 
  • Futu (FHL) on March 7. 

IPO quiet period expirations
There are also quiet period expirations for

  • Alector (NASDAQ:ALEC) on March 4 and 
  • both Harpoon Therapeutics (NASDAQ:HARP) and Gossamer Bio (NASDAQ:GOSS) on March 5.